
Anua

Sunscreens
This formula needs extra consideration during pregnancy. Review the flagged ingredients with your healthcare professional.
41 of 41 ingredients rated
MamaSkin rates the recorded formula for Anua Heartleaf Silky Moisture Sun Cream SPF 50+ as Medium risk (58/100). Discuss the flagged ingredients with a qualified healthcare professional before using this formula during pregnancy.
Manual review 2026-07-29: this formula contains polygonum cuspidatum root extract. Japanese knotweed root is classified as Low Risk because it is a source of resveratrol and follows MamaSkin's existing precautionary topical-resveratrol policy. These are precautionary topical classifications, not evidence that normal cosmetic use is a known pregnancy contraindication. Manual review 2026-09-18 (1.3.7 ingredient publication): newly tracked pregnancy-screening ingredient(s): Anastatica hierochuntica extract. The classification reflects the reviewed evidence and normal cosmetic exposure; oral, medicinal, spray or concentrated exposure may not be equivalent. The product score was recomputed against the full tracked ingredient catalogue.
41 of 41 ingredient entries on this page have a recorded score, evidence summary and source text. That describes documentation coverage, not proof that the finished formula has been clinically tested during pregnancy.
How we assess productsThe recorded formula, with evidence behind each rating. Unmatched ingredients are marked Not assessed in grey.
Animal studies of orally administered aqueous Anastatica hierochuntica extract found fetal growth and developmental effects, including at 250 mg/kg. These doses are much higher than expected from cosmetics, but the direct prenatal findings support a precautionary Medium Risk classification.
Sources: https://pubmed.ncbi.nlm.nih.gov/31445135/, https://pubmed.ncbi.nlm.nih.gov/35626940/, https://pmc.ncbi.nlm.nih.gov/articles/PMC9140171/, https://pubmed.ncbi.nlm.nih.gov/29237294/
Polygonum cuspidatum root extract, also called Japanese knotweed root extract, is a botanical source of resveratrol, polydatin and related polyphenols. Extract composition and cosmetic concentration vary, and normal topical exposure is expected to be much lower than high-dose oral supplementation. MamaSkin applies a precautionary Low Risk classification for consistency with its existing topical resveratrol policy, not because cosmetic use is a known pregnancy contraindication.
Sources: PubMed: Polygonum cuspidatum root contains resveratrol, polydatin and emodin https://pubmed.ncbi.nlm.nih.gov/23075087/; PubMed: Polygonum cuspidatum as a concentrated resveratrol source https://pubmed.ncbi.nlm.nih.gov/29403824/; PubMed: cautionary pregnancy findings from high-dose oral resveratrol in nonhuman primates https://pubmed.ncbi.nlm.nih.gov/24563374/; PubMed: topical resveratrol delivery and skin disposition https://pubmed.ncbi.nlm.nih.gov/28389713/; existing MamaSkin resveratrol policy.
Water (Aqua) is the standard purified water used as a cosmetic solvent. It has no pregnancy-specific risk in normal topical use.
Sources: https://pubchem.ncbi.nlm.nih.gov/compound/Water, https://single-market-economy.ec.europa.eu/sectors/cosmetics/cosmetic-ingredient-database/cosing-glossary-ingredients_en
A diester used as an emollient, solvent and plasticizer. After reviewing additional dermal, reproductive, developmental and genotoxicity data, cosmetic safety reviewers concluded that dibutyl adipate is safe in current cosmetic use and concentration. No pregnancy-specific concern is identified for normal topical cosmetic exposure.
Sources: CIR: Amended Final Report of the Safety Assessment of Dibutyl Adipate https://cir-reports.cir-safety.org/view-attachment?id=f1624b41-8e74-ec11-8943-0022482f06a6
Solvent and humectant used to improve texture and ingredient solubility. Low systemic exposure expected from topical cosmetic use.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
UV filter used in sunscreens and day products to help absorb UVB radiation. Reviewed cosmetic safety and regulatory sources support current cosmetic use within applicable concentration limits, with no pregnancy- or breastfeeding-specific topical concern identified in the material reviewed.
Sources: EU CosIng Annex VI / UV filters; EU scientific opinion on Ethylhexyl Triazone (Uvinul T 150)
Organic UVA filter used in sunscreens, also known as Ecamsule or Mexoryl SX. Cosmetic safety and regulatory sources support use within applicable concentration limits, with no pregnancy- or breastfeeding-specific topical concern identified in the sources reviewed.
Sources: EU CosIng Annex VI / UV filters; SCCS / European Commission cosmetic UV filter safety assessments; PubMed
Glycerin is a widely used humectant that supports hydration and the skin barrier, with a long safety record and no known pregnancy or breastfeeding concerns in topical cosmetic use.
Sources: CIR; EU/UK Cosmetics Regulation
Niacinamide (vitamin B3) is widely used for barrier support and tone/texture benefits, and is generally considered safe in pregnancy and breastfeeding when used topically at cosmetic concentrations.
Sources: CIR; EU/UK Cosmetics Regulation
Volatile/low-residue silicone emollient used to improve spreadability and sensory feel. Reviewed cosmetic safety sources support normal topical use, with no pregnancy- or breastfeeding-specific topical signal identified in the material reviewed.
Sources: CIR: Amended Safety Assessment of Dimethicone, Methicone, and Substituted-Methicone Polymers as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
A silicone resin used as a film former, texture enhancer and opacifying ingredient in makeup, sunscreen and skin care. The Cosmetic Ingredient Review concluded that polysilsesquioxanes including Polymethylsilsesquioxane are safe in current cosmetic use. Available evidence does not identify a pregnancy- or breastfeeding-specific concern for normal topical cosmetic exposure.
Sources: CIR: Safety Assessment of Polysilsesquioxanes as Used in Cosmetics (Final Report) https://cir-safety.org/sites/default/files/PLYSIL122017FR.pdf
pH adjuster and buffer used to stabilise formulations. Reviewed cosmetic safety sources support normal topical use, with no pregnancy- or breastfeeding-specific topical signal identified in the material reviewed.
Sources: CIR: Safety Assessment of Tromethamine as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
1,2-Hexanediol is commonly used as a solvent and preservative booster; topical exposure is low and it has no known pregnancy or breastfeeding concerns at cosmetic concentrations, though very sensitive skin may occasionally react.
Sources: CIR; EU/UK Cosmetics Regulation
A polyglycerin fatty-acid ester used as an emulsifier, dispersant or emollient. Cosmetic safety reviewers concluded that the assessed family of 274 polyglyceryl fatty acid esters is safe in current practices when formulated to be non-irritating. No pregnancy-specific concern was identified for normal topical cosmetic exposure.
Sources: CIR: Safety Assessment of Polyglyceryl Fatty Acid Esters as Used in Cosmetics https://www.cir-safety.org/supplementaldoc/safety-assessment-polyglyceryl-fatty-acid-esters-used-cosmetics-1
Fatty alcohol used as an emollient and thickener. Not the same as drying alcohols and not associated with pregnancy-specific concerns.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Humectant and preservative booster. Considered safe for cosmetic use with low systemic exposure.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Solvent and humectant commonly used in leave-on products. Not associated with pregnancy-specific concerns at cosmetic exposure levels.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Modern UVA filter (often called Uvinul A+ or DHHB). Regulatory assessments have repeatedly evaluated this filter as safe in cosmetic products at concentrations up to 10%. The most recent SCCS advice focuses on controlling a manufacturing impurity (DnHexP) rather than on new toxicity of DHHB itself. Human biomonitoring data indicate low systemic exposure from normal sunscreen use, and current reviews do not identify specific reproductive or developmental toxicity signals at approved concentrations.
Sources: SCCP opinion referenced in Directive 2008/123/EC: concludes that Diethylamino Hydroxybenzoyl Hexyl Benzoate used at a maximum of 10% in cosmetic (including sunscreen) products does not pose a risk to the consumer. Regulatory summaries (e.g. CosLaw and CIRS Group updates, 2025) reviewing the SCCS DHHB opinion and reiterating that DHHB remains permitted up to 10% in EU cosmetics when impurity limits are respected.
Silicone-based organic UVB filter used in sunscreens and UV-protective cosmetics. SCCS reviewed Polysilicone-15 for cosmetic use, and no pregnancy- or breastfeeding-specific topical concern was identified in the sources reviewed.
Sources: EU CosIng Annex VI / UV filters; SCCS Opinion on Polysilicone-15 (SCCS/1346/10); PubMed
A heartleaf extract used for skin conditioning and soothing. No pregnancy- or breastfeeding-specific hazard was identified for normal topical cosmetic exposure. Direct ingredient-specific pregnancy studies were not identified, so this assessment does not extend to oral supplements or medicinal use.
Sources: European Commission CosIng ingredient inventory; Cosmetic Ingredient Review botanical safety-assessment framework and relevant ingredient-family assessments. No ingredient-specific human pregnancy study of normal topical cosmetic use was identified.
A botanical extract, juice or water used primarily for skin conditioning, moisturising, soothing or antioxidant support. Direct pregnancy studies of the named cosmetic material were not identified. No reproductive or developmental hazard was identified for normal topical exposure to a compliant finished cosmetic; oral herbal or medicinal use is outside this classification.
Sources: European Commission CosIng ingredient inventory; Cosmetic Ingredient Review botanical safety-assessment framework and relevant plant-family assessments. No ingredient-specific human pregnancy study of normal topical cosmetic use was identified.
A grape fruit or seed extract used for skin conditioning and antioxidant support. Cosmetic safety reviewers concluded that the assessed Vitis vinifera-derived ingredients are safe in current practices when formulated to be non-irritating and non-sensitising. Botanical sensitivity remains possible.
Sources: CIR: Safety Assessment of Vitis vinifera (Grape)-Derived Ingredients as Used in Cosmetics https://www.cir-safety.org/supplementaldoc/safety-assessment-vitis-vinifera-grape-derived-ingredients-used-cosmetics
A botanical extract, juice or water used primarily for skin conditioning, moisturising, soothing or antioxidant support. Direct pregnancy studies of the named cosmetic material were not identified. No reproductive or developmental hazard was identified for normal topical exposure to a compliant finished cosmetic; oral herbal or medicinal use is outside this classification.
Sources: European Commission CosIng ingredient inventory; Cosmetic Ingredient Review botanical safety-assessment framework and relevant plant-family assessments. No ingredient-specific human pregnancy study of normal topical cosmetic use was identified.
A fruit, seed or food-plant extract used for skin conditioning and antioxidant support. No pregnancy-specific signal was identified for the low topical exposure expected from a finished cosmetic. Direct pregnancy studies are generally unavailable, and botanical allergy remains possible.
Sources: European Commission CosIng ingredient inventory; CIR botanical safety framework and relevant fruit-derived ingredient assessments; peer-reviewed cosmetic and phytochemical literature for the named plants.
Camellia sinensis (green tea) leaf extract is used as an antioxidant botanical; topical cosmetic use is considered low concern with no known pregnancy or breastfeeding risks, though rare sensitivities are possible.
Sources: CIR; EU/UK Cosmetics Regulation
A botanical extract or plant water used for conditioning, soothing or antioxidant support. Direct pregnancy studies of this exact cosmetic material were not identified, but no reproductive or developmental hazard was identified for normal topical exposure. Oral herbal or medicinal use is outside this classification.
Sources: European Commission CosIng; CIR botanical safety framework and relevant plant-family assessments; no ingredient-specific human pregnancy study of normal topical cosmetic use was identified.
A botanical extract, juice or water used primarily for skin conditioning, moisturising, soothing or antioxidant support. Direct pregnancy studies of the named cosmetic material were not identified. No reproductive or developmental hazard was identified for normal topical exposure to a compliant finished cosmetic; oral herbal or medicinal use is outside this classification.
Sources: European Commission CosIng ingredient inventory; Cosmetic Ingredient Review botanical safety-assessment framework and relevant plant-family assessments. No ingredient-specific human pregnancy study of normal topical cosmetic use was identified.
Panthenol (pro-vitamin B5) is used for soothing and barrier support and is generally well tolerated, with no known pregnancy or breastfeeding concerns in topical cosmetic use.
Sources: CIR; EU/UK Cosmetics Regulation
Emulsifier and emollient used to stabilise creams and lotions. Not associated with pregnancy-specific concerns at cosmetic exposure.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Modern broad-spectrum UV filter (often known as Tinosorb S). It has a high molecular weight and is formulated to remain mainly in the outer skin layers, with very low systemic absorption at cosmetic use levels. EU regulatory assessments and independent risk–benefit reviews have evaluated this filter as safe up to 10% in sunscreens, with no specific reproductive or developmental toxicity signals identified in animals or humans at permitted concentrations.
Sources: European Union Cosmetic Products Regulation (Annex VI): Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine listed as an approved UV filter up to 10% in cosmetic products. Mikkelsen SH et al. “Survey and health assessment of UV filters” – Danish EPA, 2015: includes Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine and notes low systemic exposure at approved use levels.
An alkyl phosphate surfactant and emulsifier used to stabilise creams, sunscreens and makeup. Cosmetic safety reviewers concluded that the assessed alkyl phosphates, including potassium cetyl phosphate, are safe in current practices of use and concentration when formulated to be non-irritating. Dermal penetration is expected to be limited, and no pregnancy-specific concern is identified for normal topical cosmetic exposure.
Sources: CIR: Safety Assessment of Alkyl Phosphates https://www.cir-safety.org/sites/default/files/alkyl%20phosphates_0.pdf
Solvent and humectant used to improve texture and ingredient delivery in topical cosmetic formulas. Reviewed cosmetic ingredient references do not identify a pregnancy- or breastfeeding-specific concern for normal topical use.
Sources: CIR cosmetic ingredient safety references for alkane diols; EU CosIng / cosmetics regulatory inventory
Polymer thickener used to create gel textures. Large-molecule ingredient with negligible systemic absorption.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Emulsifier and emollient ester used to stabilise creams and improve skin feel. Reviewed cosmetic safety sources support topical cosmetic use; the relevant practical caveat is formulation irritation potential rather than a pregnancy-specific concern.
Sources: CIR: Safety Assessment of Glyceryl Diesters as Used in Cosmetics; CIR Quick Reference Table (Glyceryl Stearate Citrate); EU CosIng / cosmetics regulatory inventory
Polymer thickener and stabiliser used in creams and sunscreens. Low systemic exposure expected.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Polymer thickener used to stabilise emulsions. Large-molecule ingredient with low systemic absorption.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Skin-conditioning ingredient commonly used in leave-on skincare. Reviewed cosmetic safety sources support normal topical use, with no pregnancy- or breastfeeding-specific topical signal identified in the material reviewed.
Sources: CIR: Safety Assessment of Adenosine Ingredients as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
A high-molecular-weight polymer used for film formation, texture, stabilisation or conditioning. Meaningful dermal absorption of the intact polymer is expected to be limited, and no reproductive or developmental concern was identified for normal topical cosmetic use.
Sources: European Commission CosIng ingredient inventory; CIR cosmetic-polymer safety framework and relevant polymer-family assessments.
Microbial polysaccharide used for film forming, soothing, and hydration support. Reviewed cosmetic safety sources support normal topical use, with no pregnancy- or breastfeeding-specific topical signal identified in the material reviewed.
Sources: CIR: Safety Assessment of Microbial Polysaccharide Gums as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
Vitamin E antioxidant used to protect oils and support the skin barrier. Not associated with pregnancy-specific concerns at cosmetic exposure.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Preservative booster and skin-conditioning agent. Considered safe for cosmetic use with low systemic exposure when used as intended.
Sources: Scientific Committee on Consumer Safety (EU); Cosmetic Ingredient Review (US)
Water, Dibutyl Adipate, Propanediol, Ethylhexyl Triazone, Terephthalylidene Dicamphor Sulfonic Acid, Glycerin, Niacinamide, Caprylyl Methicone, Polymethylsilsesquioxane, Tromethamine, 1,2-Hexanediol, Polyglyceryl-3 Distearate, Cetearyl Alcohol, Pentylene Glycol, Butylene Glycol, Diethylamino Hydroxybenzoyl Hexyl Benzoate, Polysilicone-15, Houttuynia Cordata Extract, Diospyros Kaki Leaf Extract, Vitis Vinifera Fruit Extract, Carthamus Tinctorius Flower Extract, Coffea Arabica Seed Extract, Polygonum Cuspidatum Root Extract, Camellia Sinensis Leaf Extract, Castanea Crenata Shell Extract, Zanthoxylum Piperitum Fruit Extract, Anastatica Hierochuntica Extract, Panthenol, Glyceryl Stearate, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine, Potassium Cetyl Phosphate, Methylpropanediol, Carbomer, Glyceryl Stearate Citrate, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Ammonium Acryloyldimethyltaurate/Vp Copolymer, Adenosine, Polyether-1, Biosaccharide Gum-1, Tocopherol, Ethylhexylglycerin
Ingredient ratings refreshed 1 October 2026. Formulas vary by market and can change. Always compare with your packaging.
Manual review 2026-07-29: this formula contains polygonum cuspidatum root extract. Japanese knotweed root is classified as Low Risk because it is a source of resveratrol and follows MamaSkin's existing precautionary topical-resveratrol policy. These are precautionary topical classifications, not evidence that normal cosmetic use is a known pregnancy contraindication. Manual review 2026-09-18 (1.3.7 ingredient publication): newly tracked pregnancy-screening ingredient(s): Anastatica hierochuntica extract. The classification reflects the reviewed evidence and normal cosmetic exposure; oral, medicinal, spray or concentrated exposure may not be equivalent. The product score was recomputed against the full tracked ingredient catalogue. The product score is a stored assessment, not a clinical safety guarantee.
No. The score and risk band describe MamaSkin's pregnancy-focused ingredient screening of this recorded formula. They do not measure SPF, UVA protection, water resistance or whether you have applied enough sunscreen. Use the protection and application instructions on your exact packaging, and review the ingredient flags separately.
41 of 41 ingredient entries on this page have a recorded score, evidence summary and source text. That describes documentation coverage, not proof that the finished formula has been clinically tested during pregnancy.
Only if the ingredient list on your packaging matches the recorded formula shown here. Formulas can differ by market and change over time. Compare the full list, not just the product name; report a mismatch if it differs.
No. This page presents a pregnancy-focused product assessment. Do not infer a breastfeeding conclusion from its score or label; breastfeeding requires a separate assessment of the formula and how it is used.